Knowridge1d
Advancing cancer risk assessment: new insights into BRCA2 gene variants
A groundbreaking study led by the Mayo Clinic Comprehensive Cancer Center has significantly deepened our understanding of ...
Myriad Genetics Signs Agreement with Nationally Renowned Sports Broadcaster Hannah Storm to Promote the Importance of Knowing Family Cancer History
SALT LAKE CITY, Jan. 09, 2025 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (NASDAQ: MYGN), a leader in genetic testing and precision medicine, announced an agreement with Hannah Storm, a nationally ...
ORACLE lung cancer test predicts survival in early stages better than current methods
Researchers at the Francis Crick Institute, the UCL Cancer Institute and UCLH have shown that a test called ORACLE can ...
News Medical2d
New test predicts lung cancer survival better than current standards
Researchers at the Francis Crick Institute, the UCL Cancer Institute and UCLH have shown that a test called ORACLE can predict lung cancer survival at the point of diagnosis better than currently used ...
News Medical2d
Functional characterization of variants improves cancer risk assessment and treatment
Findings from a multi-institutional, international study led by researchers from the Mayo Clinic Comprehensive Cancer Center have significantly advanced the understanding of genetic alterations in the ...
EurekAlert!2d
Lung cancer test predicts survival in early stages better than current methods
Researchers at the Francis Crick Institute, the UCL Cancer Institute and UCLH have shown that a test called ORACLE can predict lung cancer survival at the point of diagnosis better than currently used ...
EurekAlert!2d
First-of-its-kind blood test for head and neck cancer
Developed at the University of Michigan, MyHPVscore is a highly accurate blood test that can detect human papilloma virus-related head and neck cancer by measuring fragments of tumor DNA in a ...
Science Daily3d
Researchers resolve uncertainty in BRCA2 testing, improving cancer risk assessment and patient care
Findings from a multi-institutional, international study have significantly advanced the understanding of genetic alterations in the BRCA2 gene, a key player in hereditary cancer risk.
Improving cancer risk assessment and patient care: Researchers resolve uncertainty in BRCA2 testing
Findings from a multi-institutional, international study led by researchers from the Mayo Clinic Comprehensive Cancer Center ...
devdiscourse3d
Decoding BRCA2: Groundbreaking Insights Shed Light on Cancer Gene Mutations
Scientists have analyzed thousands of mutations in the BRCA2 cancer gene, offering crucial insights. This research could help mitigate patient concerns or guide tailored treatments. By utilizing ...
Study identifies risk potential for thousands of mutations of a cancer gene
Scientists have characterized the role of thousands of mutations in the BRCA2 cancer gene, findings that may help reassure ...
GEN3d
Novel Mechanism in DNA Damage Unraveled
A research team from the University of California (UC), Irvine, has revealed a previously unknown mechanism that triggers an inflammatory immune response in cells when their DNA is damaged. The ...